We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$269M
AUM Growth
-$24.5M
Cap. Flow
-$35.3M
Cap. Flow %
-13.1%
Top 10 Hldgs %
26.19%
Holding
93
New
19
Increased
21
Reduced
26
Closed
25

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.83M
2
UHS icon
Universal Health Services
UHS
+$6.41M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.69M
4
VTRS icon
Viatris
VTRS
+$4.59M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.18M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$8.51M
2
A icon
Agilent Technologies
A
+$6.74M
3
GILD icon
Gilead Sciences
GILD
+$6.48M
4
RVTY icon
Revvity
RVTY
+$6.21M
5
AET
Aetna Inc
AET
+$6.01M

Sector Composition

Rank Sector Weight
1 Healthcare 92.73%
2 Financials 1.34%
3 Energy 1.14%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYK icon
26
Stryker
SYK
$132B
$4.64M 1.72%
30,000
-20,000
-40% -$3.05M
BMY icon
27
Bristol-Myers Squibb
BMY
$133B
$4.6M 1.71%
+75,000
New +$4.69M
ZTS icon
28
Zoetis
ZTS
$30.9B
$4.32M 1.6%
60,000
-5,000
-8% -$343K
JNJ icon
29
Johnson & Johnson
JNJ
$624B
$4.19M 1.56%
+30,000
New +$4.18M
GWPH
30
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.96M 1.47%
30,000
+5,000
+20% +$587K
BDX icon
31
Becton Dickinson
BDX
$48.7B
$3.65M 1.35%
17,464
-15,849
-48% -$3.32M
AET
32
DELISTED
Aetna Inc
AET
$3.61M 1.34%
20,000
-35,000
-64% -$6.01M
BLUE
33
DELISTED
bluebird bio
BLUE
$3.56M 1.32%
1,544
+193
+14% +$392K
ALGN icon
34
Align Technology
ALGN
$12.5B
$3.56M 1.32%
16,000
+2,600
+19% +$591K
PBYI icon
35
Puma Biotechnology
PBYI
$450M
$3.46M 1.28%
35,000
+15,000
+75% +$1.68M
PODD icon
36
Insulet
PODD
$9.86B
$3.45M 1.28%
+50,000
New +$3.28M
SNN icon
37
Smith & Nephew
SNN
$12.6B
$3.33M 1.23%
95,000
-25,000
-21% -$909K
SAGE
38
DELISTED
Sage Therapeutics
SAGE
$3.29M 1.22%
+20,000
New +$1.94M
ILMN icon
39
Illumina
ILMN
$29B
$3.28M 1.22%
15,420
– –
LH icon
40
Labcorp
LH
$25.9B
$3.19M 1.18%
23,280
+7,100
+44% +$938K
CTLT
41
DELISTED
CATALENT, INC.
CTLT
$3.08M 1.14%
75,000
+33,600
+81% +$1.37M
LHCG
42
DELISTED
LHC Group LLC
LHCG
$3.06M 1.14%
50,000
-910
-2% -$60.2K
THC icon
43
Tenet Healthcare
THC
$21B
$3.03M 1.13%
+200,000
New +$2.81M
BIO icon
44
Bio-Rad Laboratories Class A
BIO
$9.38B
$2.98M 1.11%
12,500
+2,500
+25% +$606K
EVHC
45
DELISTED
Envision Healthcare Holdings Inc
EVHC
$2.94M 1.09%
+85,000
New +$2.97M
RDY icon
46
Dr. Reddy's Laboratories
RDY
$10.1B
$2.82M 1.05%
375,000
+125,000
+50% +$900K
LPNT
47
DELISTED
LifePoint Health, Inc.
LPNT
$2.74M 1.02%
+55,000
New +$2.73M
NBIX icon
48
Neurocrine Biosciences
NBIX
$16.7B
$2.72M 1.01%
35,000
+5,000
+17% +$341K
NVO
49
Novo Nordisk
NVO
$209B
$2.68M 1%
+100,000
New +$2.54M
ESRX
50
DELISTED
Express Scripts Holding Company
ESRX
$2.61M 0.97%
35,000
+5,000
+17% +$320K
1
2
3 4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q4 2017 Portfolio in Review

As of Q4 2017, Sivik Global Healthcare held 93 positions worth $269M, down 8.3% from $294M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sivik Global Healthcare withdrew a net $35.3M in Q4 2017, closing 25 positions and reducing 26 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $8.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 87% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in HCA Healthcare worth $7.47M.

  • Sivik Global Healthcare's largest Q4 2017 buy was HCA Healthcare: 85,000 shares worth $7.47M.
  • Sivik Global Healthcare added most to Teva Pharmaceuticals in Q4 2017, an estimated $2.63M increase.
  • Sivik Global Healthcare's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $6.01M.
  • Sivik Global Healthcare fully exited Thermo Fisher Scientific in Q4 2017, selling an estimated $8.51M.
  • Sivik Global Healthcare's ten largest holdings make up 26% of its $269M portfolio in Q4 2017.
  • Sivik Global Healthcare opened 19 new positions and closed 25 in Q4 2017.
  • Sivik Global Healthcare's portfolio value fell 8.3% quarter-over-quarter to $269M.

Based on Sivik Global Healthcare's 13F filing for Q4 2017, filed 8 Feb 2018.